Virtus ETF Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,188
| Closed | -$115K | – | 485 |
|
|
2022
Q1 | $115K | Sell |
15,188
-900
| -6% | -$6.82K | 0.05% | 280 |
|
|
2021
Q4 | $164K | Buy |
16,088
+6,745
| +72% | +$68.8K | 0.06% | 315 |
|
|
2021
Q3 | $125K | Sell |
9,343
-489
| -5% | -$6.54K | 0.06% | 369 |
|
|
2021
Q2 | $216K | Sell |
9,832
-5,487
| -36% | -$121K | 0.09% | 287 |
|
|
2021
Q1 | $369K | Buy |
15,319
+264
| +2% | +$6.36K | 0.16% | 197 |
|
|
2020
Q4 | $271K | Sell |
15,055
-1,658
| -10% | -$29.8K | 0.11% | 273 |
|
|
2020
Q3 | $193K | Sell |
16,713
-2,278
| -12% | -$26.3K | 0.1% | 301 |
|
|
2020
Q2 | $461K | Buy |
18,991
+4,428
| +30% | +$107K | 0.22% | 161 |
|
|
2020
Q1 | $160K | Sell |
14,563
-2,121
| -13% | -$23.3K | 0.07% | 285 |
|
|
2019
Q4 | $441K | Buy |
16,684
+3,081
| +23% | +$81.4K | 0.07% | 226 |
|
|
2019
Q3 | $310K | Sell |
13,603
-757
| -5% | -$17.3K | 0.06% | 196 |
|
|
2019
Q2 | $440K | Buy |
14,360
+5,706
| +66% | +$175K | 0.09% | 190 |
|
|
2019
Q1 | $144K | Sell |
8,654
-1,300
| -13% | -$21.6K | 0.31% | 95 |
|
|
2018
Q4 | $191K | Sell |
9,954
-607
| -6% | -$11.6K | 0.03% | 179 |
|
|
2018
Q3 | $552K | Sell |
10,561
-7,542
| -42% | -$394K | 0.06% | 111 |
|
|
2018
Q2 | $787K | Sell |
18,103
-20,022
| -53% | -$870K | 0.7% | 38 |
|
|
2018
Q1 | $1.41M | Buy |
38,125
+20,478
| +116% | +$759K | 1.23% | 8 |
|
|
2017
Q4 | $350K | Buy |
+17,647
| New | +$350K | 0.44% | 86 |
|